ID

34777

Beskrivning

Nutritional Intervention With Moderately High-protein, Low-glycemic Load Products in Type-2 Diabetes Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01264523

Länk

https://clinicaltrials.gov/show/NCT01264523

Nyckelord

Versioner (1)
  1. 2019-01-28 2019-01-28 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

28 januari 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Type-2 Diabetes NCT01264523

Engelsk

Eligibility Type-2 Diabetes NCT01264523

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
clinically diagnosed of type-2 diabetes
Beskrivning

Diabetes Mellitus, Non-Insulin-Dependent

Datatyp

boolean

Alias
UMLS CUI [1]
C0011860
under dietary treatment or with metformin
Beskrivning

Diet therapy | Metformin

Datatyp

boolean

Alias
UMLS CUI [1]
C0012159
UMLS CUI [2]
C0025598
body mass index (bmi) between 22 and 35 kg/m2
Beskrivning

Body mass index

Datatyp

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
bmi under 22 or over 35 kg/m2
Beskrivning

Body mass index

Datatyp

boolean

Alias
UMLS CUI [1]
C1305855
to follow a pharmacological treatment with other drugs but metformin
Beskrivning

Pharmacotherapy | Exception Metformin

Datatyp

boolean

Alias
UMLS CUI [1]
C0013216
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0025598
to be already insulin-dependent
Beskrivning

Dependence on Insulin

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0439857
UMLS CUI [1,2]
C0021641
to have other concomitant pharmacological treatments for weight loss, hormonal substitutive therapy, altered thyroid function, etc. without an stable dosage (at least three months prior the beginning of the study).
Beskrivning

Weight-Loss Agents | Hormone replacement therapy | Thyroid function altered

Datatyp

boolean

Alias
UMLS CUI [1]
C0376606
UMLS CUI [2]
C0282402
UMLS CUI [3,1]
C2242456
UMLS CUI [3,2]
C0392747
to suffer from complications due to type 2 diabetes (microangiopathy, polyneuropathy, cardiopathy, hepatic and renal impairments, etc)
Beskrivning

Complications Due to Non-Insulin-Dependent Diabetes Mellitus | Microangiopathy | Polyneuropathy | Heart Disease | Hepatic impairment | Renal Insufficiency

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0011860
UMLS CUI [2]
C0155765
UMLS CUI [3]
C0152025
UMLS CUI [4]
C0018799
UMLS CUI [5]
C0948807
UMLS CUI [6]
C1565489
to have a recent (less than 3 months before the beginning of the study) uncontrolled diagnostic of hypercholesterolemia and/or hypertriglyceridemia.
Beskrivning

Hypercholesterolemia Uncontrolled | Hypertriglyceridemia Uncontrolled

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020443
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0020557
UMLS CUI [2,2]
C0205318
Tillbaka till toppen

Similar models

Eligibility Type-2 Diabetes NCT01264523

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
clinically diagnosed of type-2 diabetes
boolean
C0011860 (UMLS CUI [1])
Diet therapy | Metformin
Item
under dietary treatment or with metformin
boolean
C0012159 (UMLS CUI [1])
C0025598 (UMLS CUI [2])
Body mass index
Item
body mass index (bmi) between 22 and 35 kg/m2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Body mass index
Item
bmi under 22 or over 35 kg/m2
boolean
C1305855 (UMLS CUI [1])
Pharmacotherapy | Exception Metformin
Item
to follow a pharmacological treatment with other drugs but metformin
boolean
C0013216 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0025598 (UMLS CUI [2,2])
Dependence on Insulin
Item
to be already insulin-dependent
boolean
C0439857 (UMLS CUI [1,1])
C0021641 (UMLS CUI [1,2])
Weight-Loss Agents | Hormone replacement therapy | Thyroid function altered
Item
to have other concomitant pharmacological treatments for weight loss, hormonal substitutive therapy, altered thyroid function, etc. without an stable dosage (at least three months prior the beginning of the study).
boolean
C0376606 (UMLS CUI [1])
C0282402 (UMLS CUI [2])
C2242456 (UMLS CUI [3,1])
C0392747 (UMLS CUI [3,2])
Complications Due to Non-Insulin-Dependent Diabetes Mellitus | Microangiopathy | Polyneuropathy | Heart Disease | Hepatic impairment | Renal Insufficiency
Item
to suffer from complications due to type 2 diabetes (microangiopathy, polyneuropathy, cardiopathy, hepatic and renal impairments, etc)
boolean
C0009566 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0011860 (UMLS CUI [1,3])
C0155765 (UMLS CUI [2])
C0152025 (UMLS CUI [3])
C0018799 (UMLS CUI [4])
C0948807 (UMLS CUI [5])
C1565489 (UMLS CUI [6])
Hypercholesterolemia Uncontrolled | Hypertriglyceridemia Uncontrolled
Item
to have a recent (less than 3 months before the beginning of the study) uncontrolled diagnostic of hypercholesterolemia and/or hypertriglyceridemia.
boolean
C0020443 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0020557 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial